respiratory pharamcology Flashcards
what are the main characteristics of asthma
- airway inflammation
- obstruction
- bronchial hyper-responsiveness
mild asthma characteristics
- below best level of function due to wheeze
- PEFR >75% best predicted
moderate asthma characteristics
- PEFR >50-75% best or predicted
- able to speak sentences
- increasing symptoms: HR and RR
acute severe asthma characteristics
- PEFR 33-50% best or predicted
- SpO2 >92%
- inability to complete sentences in one breath
- HR >110
- RR >25
life threatening asthma characteristics
- PEFR <33%
- Spo2 <92%
- altered level of conscious
- exhaustion
- cyanosis
- poor respiratory effort
- arrhythmia
- hypotension
what is the mechanism of actions of B2-adrenoceptor agonist (bronchodilators)
- mimic action of the natural ligand - adrenaline or noradrenaline
- activated receptors cause bronchodilation
what are examples of short acting b-agonists (bronchodilators)
- salbutamol
- terbutaline
what are features of short acting b-agonists
- inhalation
- short onset and duration of action
- relievers
- as you need basis
what are examples of long acting B-agonists (bronchodilators)
- salmeterol
- formoterol
what are features of long acting B-agonists
- inhalation
- slow onset and long duration
- not used as needed
- add on therapy
what are adverse effects of B2-adrenoceptor agonists
- tremors
- tachycardia
what medications fall under B2-adrenoceptor agonists
- short-acting B-agonists
- long-acting B-agonists
when are inhaled corticosteroids used
moderate to severe asthma
when are oral/ systemic corticosteroids used
for severe asthma
what is the mechanism of action of corticosteroids
- inhibit production of inflammatory cytokines TNFa, IL1 and IL8
- reduces expression of inflammatory cell adhesion molecules
- inhibit gene transcription of COX2
- increase synthesis of anti-inflammatory factors
- stabilise mast cells and basophil membrane decreasing histamine release